Billionaire Profile
Roger Samuelsson
Global Rank
#1011

Image: Steptyro | CC BY-SA 4.0 | via Wikimedia Commons

Roger Samuelsson

CEO, Drug delivery devices
SWEDEN
Real-Time Net Worth
$4.141B
Estimated based on Drug delivery devices stock value as of March 6, 2026
0% (24h)
Age
62
Source
Drug delivery devices
Industry
Healthcare
Citizenship
SWEDEN

Biography

Roger Samuelsson is a Swedish entrepreneur, currently estimated to be worth $3 billion. His wealth stems from his ownership of 69% of SHL Medical, a leading manufacturer of autoinjectors used in the healthcare industry. Samuelsson's career began in Taiwan, where he started a trading business before establishing SHL Medical in 1989. His achievements include building SHL Medical into a global leader, controlling 25% of the global market for autoinjectors, and expanding the company's reach to include major pharmaceutical clients like Novo Nordisk, Amgen, and Pfizer. He also owns the megayacht Octopus, previously owned by Microsoft co-founder Paul Allen.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Roger Ivar Samuelsson was born on December 10, 1963, in Svalöv, Sweden. He grew up in the Gothenburg area, including Lerum and Mjölby. As a teenager with an interest in sports, he noticed that sports equipment was often manufactured in Asia, leading him to begin importing boxing gloves and other items.

Rise to Success

After completing engineering studies at Berzeliusskolan in Linköping from 1980 to 1983, Samuelsson, at the age of 20, traveled to Taiwan to visit factories and explore goods to import to Sweden. Initially, the business was not focused, but after gaining clients like Landstingens inköpscentral and RFSU, it shifted towards technical aids for the elderly and disabled. In 1988, he moved his operations to Taipei, Taiwan, and the following year, he co-founded Scandinavian Health Systems (SHL) with a partner, initially operating from his apartment. This company evolved from a purchasing agency to a manufacturer, with its primary focus today on injectors and other systems for individual drug delivery. The company has experienced continuous growth since its inception, with factories in Taiwan and China, and development departments in Taiwan, Sweden, and the USA.

Key Business Strategies

Samuelsson's success is rooted in his strategic focus on the growing demand for autoinjectors. SHL Medical has become a major player, with 25% of the global market share. The company's products are used by 20 of the world's 25 largest pharmaceutical companies. SHL Medical controls 25% of the global market for autoinjectors. In 2020, Swedish private equity firm EQT acquired a 31% stake in SHL Medical. By focusing on innovation and in-house production, Samuelsson ensures the company meets the high standards required by its clients.

Philanthropy

The search did not yield specific information about Roger Samuelsson's philanthropic activities.

Career Milestones

1989

Founded SHL Medical

Cofounded SHL Medical in Taiwan, which manufactures autoinjectors.

2006

Contract with Amgen

Secured a contract with Amgen to manufacture autoinjectors for Enbrel.

2021

Purchased Octopus yacht

Became the owner of the megayacht Octopus.